Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production - PubMed (original) (raw)
Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production
N N Teng et al. Proc Natl Acad Sci U S A. 1983 Dec.
Abstract
FU-266, a mutant human myeloma cell line sensitive to hypoxanthine/aminopterin/thymidine (HAT), was transfected by protoplast fusion with DNA of the recombinant plasmid vector pSV2-neoR, thus acquiring a dominant marker conferring resistance to the antibiotic G-418. One of the resultant neoR clones, E-1, was fused to irradiated (500 rads) or unirradiated cells of the HAT-sensitive, G-418-sensitive, nonproducer mouse myeloma line X63-Ag8.653. Hybrid clones were selected in G-418 plus ouabain, thus preserving their HAT sensitivity. Small numbers of human chromosomes were retained in all such hybrids, but most of them ceased secreting human myeloma (IgE(lambda). Selected hybrid clones were then tested as malignant fusion partners in a series of fusions with polyclonally activated human B lymphocytes and with antigen-primed human B lymphocytes, in some instances after transformation of the latter with Epstein-Barr virus. The yield of viable chimeric hybridomas has been consistently high, as has the proportion of hybridomas secreting human immunoglobulin molecules unpermuted with mouse or human myeloma heavy or light chains. Secretion by many subcloned hybridomas has been stable for over 6 months, and several antigen-specific human monoclonal antibodies have been generated. Thus these heteromyeloma cell lines appear to have significant advantages for human monoclonal antibody production.
Similar articles
- Somatic cell hybrid selection with a transfectable dominant marker.
Riera FC, Blam SB, Teng NN, Kaplan HS. Riera FC, et al. Somat Cell Mol Genet. 1984 Mar;10(2):123-7. doi: 10.1007/BF01534901. Somat Cell Mol Genet. 1984. PMID: 6324391 - Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK, Perkins S, Raubitschek A, Larrick J, Lizak G, Fishwild D, Engleman EG, Grumet FC. Foung SK, et al. J Immunol Methods. 1984 May 11;70(1):83-90. doi: 10.1016/0022-1759(84)90392-2. J Immunol Methods. 1984. PMID: 6201562 - Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
Greenlee AR, Magnuson NS, Smith C, Butt BM, McKiernan AJ, Davis WC. Greenlee AR, et al. Vet Immunol Immunopathol. 1990 Nov;26(3):267-83. doi: 10.1016/0165-2427(90)90096-b. Vet Immunol Immunopathol. 1990. PMID: 2264287 - Novel approaches to the preparation and use of monoclonal antibodies.
Lemieux R, Bazin R. Lemieux R, et al. Transfus Med Rev. 1993 Jan;7(1):25-36. doi: 10.1016/s0887-7963(93)70030-9. Transfus Med Rev. 1993. PMID: 8381687 Review. No abstract available. - Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM. Nakamura RM. Clin Physiol Biochem. 1983;1(2-5):160-72. Clin Physiol Biochem. 1983. PMID: 6396016 Review.
Cited by
- Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
Parray HA, Shukla S, Samal S, Shrivastava T, Ahmed S, Sharma C, Kumar R. Parray HA, et al. Int Immunopharmacol. 2020 Aug;85:106639. doi: 10.1016/j.intimp.2020.106639. Epub 2020 May 27. Int Immunopharmacol. 2020. PMID: 32473573 Free PMC article. Review. - Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.
Chan KW, Pan R, Costa M, Gorny MK, Wang S, Lu S, Kong XP. Chan KW, et al. J Virol. 2018 Aug 29;92(18):e00641-18. doi: 10.1128/JVI.00641-18. Print 2018 Sep 15. J Virol. 2018. PMID: 29997214 Free PMC article. - Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.
Reed JH, Gorny MK, Li L, Cardozo T, Buyon JP, Clancy RM. Reed JH, et al. J Autoimmun. 2017 May;79:99-104. doi: 10.1016/j.jaut.2017.01.004. Epub 2017 Jan 22. J Autoimmun. 2017. PMID: 28118945 Free PMC article. - Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
von Bredow B, Arias JF, Heyer LN, Moldt B, Le K, Robinson JE, Zolla-Pazner S, Burton DR, Evans DT. von Bredow B, et al. J Virol. 2016 Jun 10;90(13):6127-6139. doi: 10.1128/JVI.00347-16. Print 2016 Jul 1. J Virol. 2016. PMID: 27122574 Free PMC article. - Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.
Smith SA, Crowe JE Jr. Smith SA, et al. Microbiol Spectr. 2015 Feb;3(1):AID-0027-2014. doi: 10.1128/microbiolspec.AID-0027-2014. Microbiol Spectr. 2015. PMID: 26104564 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1967 Sep;58(3):1104-11 - PubMed
- Nature. 1969 Jul 26;223(5204):358-63 - PubMed
- Nature. 1969 Jul 26;223(5204):363-8 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Clin Exp Immunol. 1970 Oct;7(4):477-89 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials